CORRELATION OF THE AUDITORY BRAINSTEM EVOKED POTENTIALS AMPLITUDE AND HEARING THRESHOLD SHIFT RELATED TO COCHLEAR INJURY
DOI:
https://doi.org/10.5457/ams.v37i1.58Keywords:
Hearing Loss, Noise-Induced, Auditory Brain Stem Evoked PotentialsAbstract
Introduction: We have assessed the effects of the inner ear acoustic trauma on the amplitude of the first (I) and fifth (V) wave of the auditory brainstem evoked response (ABR). The aim was to estimate the diagnostic accuracy of the auditory brainstem evoked potentials amplitude in predicting the hearing threshold. Material and Methods: The ABR and pure tone audiometric recording were taken from 132 patients exposed to acute acoustic trauma. The amplitude of the I and V ABR wave was recorded for 80 dB HL click stimulation. Test of multiple regression was performed to establish the best diagnostic combination of the I, V and V/I ABR amplitude ratio on the hearing threshold prediction at 500Hz, 1 kHz i 2 kHz frequencies. Results and Discussion: The direct correlation was eminent between the hearing threshold and amplitude of the I wave ABR (R=0.065, R=0.048 i R=0.01, p< 0.05) for all of the tested frequencies. The amplitude of I and V wave of ABR significantly predicts haring threshold in cochlear injury related to acoustic trauma (r2=0.057, p< 0.05). Amplitude of the V wave was in reverse correlation to hearing threshold on all of the examined frequencies. Conclusion: The amplitudes of the I and V ABR waves, and V/I ABR wave ratio were significantly correlated with hearing threshold at 500 Hz, 1 kHz i 2 kHz in patients with cochlear damage secondary to acoustic trauma. Inner ear injury results in significant increase of I wave amplitude, yet followed by the decrease in V wave ABR amplitude.
Downloads
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
